C07D 477/26
Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a
Official title: with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
C07D477/26 (Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a) appears on 16 US grants and 8 published applications in this corpus.
Search patents in C07D- Granted patents
- 16
- Published applications
- 8
- Assignees
- 8
- Inventors
- 40
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 5 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors3 Mar 2026US 12,565,476 B2Revolution Medicines, Inc.
- 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors30 May 2023US 11,661,401 B2Revolution Medicines, Inc.
- 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors17 Mar 2020US 10,590,090 B2Revolution Medicines, Inc.
- Methods of generating beta-lactamase resistant carbapenem compounds31 Dec 2019US 10,519,161 B2Southern Methodist University
- Method for the preparation of carbapenam compounds11 Nov 2014US 8,884,005 B2Instytut Chemi Organicznej Pan
- 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors11 Apr 2024US 2024/0116878 A1Revolution Medicines, Inc.
- 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors8 Apr 2021US 2021/0101870 A1Revolution Medicines, Inc.
- Atypical Carbapenem Antibiotics with Improved Activity Against Carbapenemase-Producing Acinetobacter baumannii29 Oct 2020US 2020/0339582 A1
- 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors11 Jul 2019US 2019/0210977 A1Revolution Medicines, Inc.
- Method for the preparation of carbapenam compounds29 May 2014US 2014/0148595 A1Instytut Chemi Organicznej Pan
Most cited
By later US patents
- 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids33US 4,232,036 AMerck & Co., Inc. · 1980
- 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid27US 4,206,219 AMerck & Co., Inc. · 1980
- 3-(2-Aminoethyl thio)-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid25US 4,234,596 AMerck & Co., Inc. · 1980
- 6-(1-Hydroxyethyl)-2-(2-aminoeth ylthio)-1-substituted-1-carbade-thiapen-2-em-3-carboxylic acids19US 4,218,462 AMerck & Co., Inc. · 1980
- 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors16US 10,590,090 B2Revolution Medicines, Inc. · 2020